<DOC>
	<DOC>NCT01951079</DOC>
	<brief_summary>In second trimester abortion above 22 weeks the investigators usually inject intra-cardiac Kcl for feticide. Digoxin intra-amniotic injection has been described in the literature in doses of 1-1.5 mg. with a success rate of about 80%, and up to 24 weeks. Our aim in this study is to investigate the safety and success rate of 1.5-2 mg. digoxin, intra-amniotic up to 30 weeks pregnancy .</brief_summary>
	<brief_title>Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy</brief_title>
	<detailed_description>- The digoxin will be injected intra-amniotic with U.S guided, trying to avoid any placental passage or intravascular injection / - Any patient will have prior to the procedure a full examination including E.C.G and cardiac clearance.</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>healthy women with no medical, cardiac, hypertension, liver or renal problems pregnant in their 2030 week gestation, that need to have abortion due to fetal anomalies or any other reason need to have feticide prior to the procedure any patient with medical problem that may be a contraindication to Digoxin cardiac problems, prior cardiac surgery, liver or kidney disease, hyper tension etc.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Digoxin</keyword>
	<keyword>Intra-amniotic injection</keyword>
	<keyword>feticide</keyword>
	<keyword>second trimester abortion</keyword>
</DOC>